The infographic covers the top-selling drugs and companies in 2032, the therapy areas growing fastest, and the dealmaking picture for companies most exposed to loss of exclusivity.
The infographic covers:
- Which drugs will top the sales rankings in 2032, and what that means for the competitive landscape
- The top 10 pharma companies by projected 2032 revenue, and who is growing fastest
- Which therapy areas are driving growth – and which are losing ground
- The companies most exposed to patent expiry through 2032, and how they are responding
